BioLife Sciences Inc. (BLFE)
BioLife Sciences Inc. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Henderson, NV, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $156,683. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -308.0%. Its beta of -2290.12 implies it has historically moved less than the broad market.
BioLife Sciences Corp. specializes in the creation, licensing, and distribution of both antibacterial solutions and advanced non-contact human temperature screening technologies. Its diverse product portfolio includes sanitizing wipes, ultraviolet (UV) sterilization equipment, professional electrostatic disinfection services, specialized anti-microbial fabrics, and innovative touch-free vending or marketplace systems. The company, which was established in 2018, operates from its base in Mississauga, Canada.
BioLife Sciences Inc. is most often compared with the following Healthcare names: